{"pmid":32412403,"title":"COVID-19 and ophthalmology: an underappreciated occupational hazard.","text":["COVID-19 and ophthalmology: an underappreciated occupational hazard.","The proximity required of a thorough biomicroscopic slit-lamp examination may put ophthalmologists at increased risk for respiratory-borne infection with SARS-CoV-2. Conjunctivitis has been described in a few patients with COVID-19 and other coronavirus syndromes. Although SARS-CoV-2 has been detected in the conjunctival secretions or tears of patients with COVID-19 and conjunctivitis, transmission of infection through respiratory droplets to ophthalmologists without eye protection or masks may be the bigger concern.","Infect Control Hosp Epidemiol","Kuo, Irene C","O'Brien, Terrence P","32412403"],"abstract":["The proximity required of a thorough biomicroscopic slit-lamp examination may put ophthalmologists at increased risk for respiratory-borne infection with SARS-CoV-2. Conjunctivitis has been described in a few patients with COVID-19 and other coronavirus syndromes. Although SARS-CoV-2 has been detected in the conjunctival secretions or tears of patients with COVID-19 and conjunctivitis, transmission of infection through respiratory droplets to ophthalmologists without eye protection or masks may be the bigger concern."],"journal":"Infect Control Hosp Epidemiol","authors":["Kuo, Irene C","O'Brien, Terrence P"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32412403","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1017/ice.2020.238","keywords":["covid-19","coronavirus","sars-cov-2","conjunctivitis","occupational health"],"topics":["Prevention"],"weight":1,"_version_":1666989866068475904,"score":9.490897,"similar":[{"pmid":32332516,"title":"Precaution and Prevention of Coronavirus Disease 2019 (COVID-19) Infection in the Eye.","text":["Precaution and Prevention of Coronavirus Disease 2019 (COVID-19) Infection in the Eye.","Although current studies suggested that conjunctivitis is not a common presentation of coronavirus disease 2019(COVID-19), several studies have reported the presence of Severe Acute Respiratory Syndrome Coronavirus-2(SARS-CoV-2) in ocular secretions. Coronavirus had not yet been successfully cultured from tears or conjunctival swabs in humans, neither SARS-CoV-2 nor SARS-CoV. However, live feline coronavirus has been isolated from conjunctival swabs. In addition, infection of COVID-19 through unprotected eye exposure had been suspected in several articles. Reports of ophthalmologists and otolaryngologists died of COVID-19 also raised concern on ocular transmission. As a result, we strongly suggest that personal protective equipment (PPE) should cover the mouth, nose, and eyes of ophthalmologists, especially when conjunctivitis caused by SARS-CoV-2 is clinically indistinguishable from other viral follicular conjunctivitis.","J Chin Med Assoc","Chen, Meng-Jou","Chang, Kao-Jung","Hsu, Chih-Chien","Lin, Pei-Yu","Liu, Catherine Jui-Ling","32332516"],"abstract":["Although current studies suggested that conjunctivitis is not a common presentation of coronavirus disease 2019(COVID-19), several studies have reported the presence of Severe Acute Respiratory Syndrome Coronavirus-2(SARS-CoV-2) in ocular secretions. Coronavirus had not yet been successfully cultured from tears or conjunctival swabs in humans, neither SARS-CoV-2 nor SARS-CoV. However, live feline coronavirus has been isolated from conjunctival swabs. In addition, infection of COVID-19 through unprotected eye exposure had been suspected in several articles. Reports of ophthalmologists and otolaryngologists died of COVID-19 also raised concern on ocular transmission. As a result, we strongly suggest that personal protective equipment (PPE) should cover the mouth, nose, and eyes of ophthalmologists, especially when conjunctivitis caused by SARS-CoV-2 is clinically indistinguishable from other viral follicular conjunctivitis."],"journal":"J Chin Med Assoc","authors":["Chen, Meng-Jou","Chang, Kao-Jung","Hsu, Chih-Chien","Lin, Pei-Yu","Liu, Catherine Jui-Ling"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32332516","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1097/JCMA.0000000000000334","topics":["Prevention"],"weight":1,"_version_":1666138493933322240,"score":277.20816},{"pmid":32445134,"title":"COVID-19 Disease and Ophthalmology: An Update.","text":["COVID-19 Disease and Ophthalmology: An Update.","The worldwide outbreak of the severe and acute respiratory coronavirus disease (COVID-19) caused by the coronavirus strain SARS-CoV-2 is currently the focal point of discussion due to the suffering this syndrome is causing to humanity. However, the ophthalmological implications of this syndrome has not yet been well described. Both eyes and tears as portals of entry and sources of contagion have been the subject of debate by many authors. The purpose of this review is to summarize the evidence currently available on COVID-19 and its ocular implications and manifestations, in both animals and humans, with the aim to facilitate prevention and educate the ophthalmological community on this subject. A review of the literature revealed that the results of some studies suggest that ocular symptoms commonly appear in patients with severe COVID-19 pneumonia and that it is possible to isolate the virus from the conjunctival sac of these patients. Conjunctivitis is not a common manifestation of the disease, but contact with infected eyes could be one route of transmission. Consequently, ophthalmologists need to have correct prevention strategies in place. Some guidelines regarding the prevention and management of ophthalmology clinics are reviewed. However, well-designed trials should be conducted to rule out other ocular manifestations that may result from COVID-19 infection and to understand the transmission of the virus through the eyes.","Ophthalmol Ther","Amesty, Maria A","Alio Del Barrio, Jorge L","Alio, Jorge L","32445134"],"abstract":["The worldwide outbreak of the severe and acute respiratory coronavirus disease (COVID-19) caused by the coronavirus strain SARS-CoV-2 is currently the focal point of discussion due to the suffering this syndrome is causing to humanity. However, the ophthalmological implications of this syndrome has not yet been well described. Both eyes and tears as portals of entry and sources of contagion have been the subject of debate by many authors. The purpose of this review is to summarize the evidence currently available on COVID-19 and its ocular implications and manifestations, in both animals and humans, with the aim to facilitate prevention and educate the ophthalmological community on this subject. A review of the literature revealed that the results of some studies suggest that ocular symptoms commonly appear in patients with severe COVID-19 pneumonia and that it is possible to isolate the virus from the conjunctival sac of these patients. Conjunctivitis is not a common manifestation of the disease, but contact with infected eyes could be one route of transmission. Consequently, ophthalmologists need to have correct prevention strategies in place. Some guidelines regarding the prevention and management of ophthalmology clinics are reviewed. However, well-designed trials should be conducted to rule out other ocular manifestations that may result from COVID-19 infection and to understand the transmission of the virus through the eyes."],"journal":"Ophthalmol Ther","authors":["Amesty, Maria A","Alio Del Barrio, Jorge L","Alio, Jorge L"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445134","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s40123-020-00260-y","keywords":["covid-1","conjunctivitis","coronavirus","ocular transmission","ophthalmology","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1667600475755642880,"score":260.81387},{"pmid":32323704,"title":"COVID-19 emergency in the cruise's ship: a case report of conjunctivitis.","text":["COVID-19 emergency in the cruise's ship: a case report of conjunctivitis.","Little is known about the Covid-19 transmission through ocular tissue, and more research needs to be carried out in order to confirm its ability to infect ocular tissue and its pathogenic mechanisms. Covid-19 may be detected in the tears and conjunctival secretions in novel coronavirus pneumonia patients with conjunctivitis. This case report shows a severe viral conjunctivitis in a patient diagnosed with Covid-19 on the Diamond Princess ship, characterized by both red, irritated and swollen eyes, with transparent serous secretions, conjunctival chemosis, pseudomembranes of fibrin and inflammatory cells on the tarsal conjunctiva accompanied by preauricular lymph nodes and enlarged submaxillaries.","Clin Ter","Salducci, M","La Torre, G","32323704"],"abstract":["Little is known about the Covid-19 transmission through ocular tissue, and more research needs to be carried out in order to confirm its ability to infect ocular tissue and its pathogenic mechanisms. Covid-19 may be detected in the tears and conjunctival secretions in novel coronavirus pneumonia patients with conjunctivitis. This case report shows a severe viral conjunctivitis in a patient diagnosed with Covid-19 on the Diamond Princess ship, characterized by both red, irritated and swollen eyes, with transparent serous secretions, conjunctival chemosis, pseudomembranes of fibrin and inflammatory cells on the tarsal conjunctiva accompanied by preauricular lymph nodes and enlarged submaxillaries."],"journal":"Clin Ter","authors":["Salducci, M","La Torre, G"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32323704","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.7417/CT.2020.2212","keywords":["covid-19","conjunctivitis","ship"],"topics":["Case Report"],"weight":1,"_version_":1666138493801201664,"score":228.93083},{"pmid":32454575,"title":"Urgent and Emergent Eye Care Strategies to Protect Against COVID-19.","text":["Urgent and Emergent Eye Care Strategies to Protect Against COVID-19.","Objective: This article presents additional strategies to the medical professional and support tactics to keep both the health care provider and patient as safe as possible during the COVID-19 pandemic. Observations: Follicular conjunctivitis has been reported as an early sign of infection or during hospitalization for severe COVID-19 disease. It has been confirmed that COVID-19 is transmitted through both respiratory droplets and direct contact. Another possible route of viral transmission is entry through aerosolized droplets into the tears, which then pass through the nasolacrimal ducts and into the respiratory tract. For nonemergent care, eye care providers should use telehealth. Eye care providers should prioritize patient care in order of absolute necessity, such as sudden vision loss, sudden onset flashes and floaters, and eye trauma. In those cases, exposure should be minimized. The close proximity between eye care providers and their patients during slit-lamp examination may require further precautions, such as shields, barriers, and mask use to lower the risk of transmission via droplets or through hand to eye contact. Conclusions: All nonemergent eye care appointments should be delayed or conducted remotely. For emergent in-person appointments, careful and appropriate adherence to Centers for Disease Control and Prevention recommendations may minimize exposure for both the health care provider and patient.","Fed Pract","Scheer, Lisette","Hillsgrove, Robert","32454575"],"abstract":["Objective: This article presents additional strategies to the medical professional and support tactics to keep both the health care provider and patient as safe as possible during the COVID-19 pandemic. Observations: Follicular conjunctivitis has been reported as an early sign of infection or during hospitalization for severe COVID-19 disease. It has been confirmed that COVID-19 is transmitted through both respiratory droplets and direct contact. Another possible route of viral transmission is entry through aerosolized droplets into the tears, which then pass through the nasolacrimal ducts and into the respiratory tract. For nonemergent care, eye care providers should use telehealth. Eye care providers should prioritize patient care in order of absolute necessity, such as sudden vision loss, sudden onset flashes and floaters, and eye trauma. In those cases, exposure should be minimized. The close proximity between eye care providers and their patients during slit-lamp examination may require further precautions, such as shields, barriers, and mask use to lower the risk of transmission via droplets or through hand to eye contact. Conclusions: All nonemergent eye care appointments should be delayed or conducted remotely. For emergent in-person appointments, careful and appropriate adherence to Centers for Disease Control and Prevention recommendations may minimize exposure for both the health care provider and patient."],"journal":"Fed Pract","authors":["Scheer, Lisette","Hillsgrove, Robert"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454575","source":"PubMed","week":"202022|May 25 - May 31","topics":["Prevention"],"weight":1,"_version_":1667881798439272448,"score":224.50232},{"pmid":32310553,"title":"Ophthalmic Manifestations Of Coronavirus (COVID-19)","text":["Ophthalmic Manifestations Of Coronavirus (COVID-19)","Since December 2019, coronavirus disease 2019 (COVID-19) has become a global pandemic caused by the highly transmissible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).[1] There have been several reports of eye redness and irritation in COVID-19 patients, both anecdotal and published, suggesting that conjunctivitis may be an ocular manifestation of SARS-CoV-2 infection. A study conducted during the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak detected SARS-CoV in tear samples in SARS patients in Singapore.[2] Lack of eye protection was a primary risk factor of SARS-CoV transmission from SARS patients to healthcare workers in Toronto, prompting a concern that respiratory illness could be transmitted through ocular secretions.[3][[4] Similar concerns have been raised with SARS-CoV-2, especially among eye care providers and those on the front lines triaging what could be initial symptoms of COVID-19. As conjunctivitis is a common eye condition, ophthalmologists may be the first medical professionals to evaluate a patient with COVID-19. Indeed, one of the first providers to voice concerns regarding the spread of Coronavirus in Chinese patients was Li Wenliang, MD, an ophthalmologist. He later died from COVID-19 and was believed to have contracted the virus from an asymptomatic glaucoma patient in his clinic. The authors of this article have attempted to collect the most up-to-date information on ophthalmic manifestations of COVID-19 as a resource for identifying symptoms, providing diagnostic pearls, and mitigating transmission.","StatPearls","Hu, Katherine","Patel, Jay","Patel, Bhupendra C.","32310553"],"abstract":["Since December 2019, coronavirus disease 2019 (COVID-19) has become a global pandemic caused by the highly transmissible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).[1] There have been several reports of eye redness and irritation in COVID-19 patients, both anecdotal and published, suggesting that conjunctivitis may be an ocular manifestation of SARS-CoV-2 infection. A study conducted during the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak detected SARS-CoV in tear samples in SARS patients in Singapore.[2] Lack of eye protection was a primary risk factor of SARS-CoV transmission from SARS patients to healthcare workers in Toronto, prompting a concern that respiratory illness could be transmitted through ocular secretions.[3][[4] Similar concerns have been raised with SARS-CoV-2, especially among eye care providers and those on the front lines triaging what could be initial symptoms of COVID-19. As conjunctivitis is a common eye condition, ophthalmologists may be the first medical professionals to evaluate a patient with COVID-19. Indeed, one of the first providers to voice concerns regarding the spread of Coronavirus in Chinese patients was Li Wenliang, MD, an ophthalmologist. He later died from COVID-19 and was believed to have contracted the virus from an asymptomatic glaucoma patient in his clinic. The authors of this article have attempted to collect the most up-to-date information on ophthalmic manifestations of COVID-19 as a resource for identifying symptoms, providing diagnostic pearls, and mitigating transmission."],"journal":"StatPearls","authors":["Hu, Katherine","Patel, Jay","Patel, Bhupendra C."],"date":"2020-04-21T11:01:00Z","year":2020,"_id":"32310553","source":"PubMed","week":"202017|Apr 20 - Apr 26","locations":["Toronto","Chinese"],"countries":["Canada","China"],"countries_codes":["CAN|Canada","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138491140964352,"score":223.29485}]}